|
US2018325851A1
|
|
Transdermally-delivered combination drug therapy for pain
|
|
WO2014144712A1
|
|
Topical formulations and methods for drug delivery
|
|
BRPI0921959A2
|
|
Tattoo Removal Methods and Compositions
|
|
EP2207536A1
|
|
Transdermal drug delivery using an osmolyte and vasoactive agent
|
|
BRPI0918142A2
|
|
topical pharmacological composition, its method of preparation, as well as use of the 2- (4-isobutyphylphenyl) propionic acid free form
|
|
CA2727710A1
|
|
Control of blood vessel physiology to treat skin disorders
|
|
WO2009094473A1
|
|
Methods and compositions for topical treatment of medical conditions including wounds and inflammation
|
|
US2008312296A1
|
|
Bifunctional synthetic molecules
|
|
CA2569285A1
|
|
Methods of device-assisted drug delivery
|
|
CA2512060A1
|
|
Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators therein
|
|
CA2512059A1
|
|
Transdermal drug delivery formulations with optimal amounts of vasodilators therein
|
|
WO2006009568A2
|
|
Peripherally-acting vasodilators
|
|
US6635274B1
|
|
Solution-based transdermal drug delivery system
|
